Jonathan R. Monson serves as Executive Vice President and Chief Financial Officer of Boston Scientific Corporation, a global medical technology leader in the development and manufacturing of innovative devices for minimally invasive procedures. Appointed to this role in October 2021, Monson oversees the company's global financial operations, including financial planning, treasury, tax, investor relations, and risk management. His strategic leadership has been instrumental in driving Boston Scientific's financial health amid rapid growth, supporting key acquisitions and investments in high-impact areas such as cardiology, endoscopy, and neuromodulation. Prior to his current position, Monson held progressive finance roles at Boston Scientific, including Senior Vice President, Controller, and Chief Accounting Officer since 2019, and Vice President roles in corporate finance and business unit leadership. Before joining the company in 2011, he spent over a decade at Covidien plc (now part of Medtronic), where he served as Vice President and CFO for the Medical Imaging and Vascular Therapy groups, managing multimillion-dollar portfolios and leading financial integrations post-acquisitions. Earlier in his career, Monson held finance positions at GE Healthcare, honing his expertise in operational finance and strategic planning. Monson's achievements include guiding Boston Scientific through significant revenue expansion, achieving record financial results, and enhancing shareholder value through disciplined capital allocation and debt management. A certified public accountant, he holds a Bachelor of Science in Finance from Bentley University and a Master of Business Administration from Babson College, bringing a blend of analytical rigor and business acumen to his executive responsibilities.